Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen Sells ProteinChip Systems to Japanese Drug Discovery Proteome Project

NEW YORK, April 19 (GenomeWeb News) - Ciphergen Biosystems announced today that its Japanese subsidiary has been named one of the official technology suppliers of the Japanese Drug Discovery Proteome Factory project.

 

Ciphergen has so far sold to the project three ProteinChip AutoBiomarker Systems and two ProteinChip interfaces for use with tandem mass spec.

 

The five-year Japanese project, which began in 2002, involves 20 Japanese pharma companies and is funded by the Japan Health Science Foundation to the tune of 4.5 billion yen ($41 million). The goal of the project is to gain information on proteins involved in cancer, diabetes, hypertension, asthma, and dementia.

 

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.